Clinical Trial Update: Pilot Clinical Evaluation to Characterize in Vivo Effects of Topically Applied ZuraPrep & ZuraPrep Vehicle [Phase 3]

View source ↗

Summary

A Phase 3 pilot clinical evaluation of topically applied ZuraPrep and its vehicle for effects related to surgical site infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Surgical Site Infection

Drugs mentioned

• ZuraPrep
• ZuraPrep Vehicle

Snippet

Sponsor: Zurex Pharma, Inc. | Conditions: Surgical Site Infection | Phase 3 | Status: COMPLETED